Prescient Therapeutics seeks to provide new tools for clinicians in combating cancer
The prestigious International Society of Cell and Gene Therapy (ISCT) will showcase two abstracts from Prescient...
The prestigious International Society of Cell and Gene Therapy (ISCT) will showcase two abstracts from Prescient...
We can profile the patient, find out what they need, we pull the appropriate targeting...
Prescient Therapeutics Ltd (ASX:PTX) CEO Steven Yatomi-Clarke updates Proactive’s Elisha Newell after the biotech showcased pre-clinical...
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) presented exciting new data on their OmniCAR...
Prescient was pleased to present data on our cell therapies at the prestigious International Society...
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has appointed highly experienced US biotech executive...
Prescient Therapeutics (ASX: PTX) -- a publicly listed oncology company developing targeted and cell therapies...
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) will present two of its abstracts at an annual...
The prestigious International Society of Cell and Gene Therapy (ISCT) will showcase two abstracts from Prescient...
ASX-listed clinical-stage oncology company Prescient Therapeutics (ASX: PTX) has informed about the appointment of Dr...

This investor centre was built by Reach Markets
©2025 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.